MAP2K7 and neoplasm: ,20,21 Avutometinib is a RAF/MEK clamp that induces formation of inactive complexes of MEK with ARAF, BRAF, and CRAF, which leads to more complete and durable anti-tumor responses through maximal MAPK pathway inhibition.